Stocktoria
WEST PHARMACEUTICAL SERVICES INC WST
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1923-07-27
WEST PHARMACEUTICAL SERVICES INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.1B | $2.9B | $2.9B | $2.9B | $2.8B |
| Gross profit | $1.1B | $998.5M | $1.1B | $1.1B | $1.2B |
| R&D expense | $74.3M | $69.1M | $68.4M | $58.5M | $52.8M |
| SG&A expense | $393.6M | $338.5M | $353.4M | $316.9M | $362.8M |
| Operating income | $584.9M | $569.9M | $676.0M | $734.0M | $752.3M |
| Interest expense | — | — | $9.0M | $7.9M | $8.2M |
| Income tax | $121.6M | $107.5M | $122.3M | $114.7M | $107.2M |
| Net income | $493.7M | $492.7M | $593.4M | $585.9M | $661.8M |
| EPS (diluted) | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 |
| Operating cash flow | $754.8M | $653.4M | $776.5M | $724.0M | $584.0M |
| Free cash flow | $468.9M | $276.4M | $414.5M | $439.4M | $330.6M |
| Cash & equivalents | $791.3M | $484.6M | $853.9M | $894.3M | $762.6M |
| Inventory | $443.9M | $377.0M | $434.7M | $414.8M | $378.4M |
| Total assets | $4.3B | $3.6B | $3.8B | $3.6B | $3.3B |
| Total liabilities | $1.1B | $961.1M | $948.5M | $931.9M | $978.4M |
| Shareholders' equity | $3.2B | $2.7B | $2.9B | $2.7B | $2.3B |
Source: SEC EDGAR filings · CIK 0000105770 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.